An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.